Vesicor Therapeutics, Inc. — Form D
Vesicor Therapeutics, Inc. of SAN GABRIEL, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-14. The offering totals $3.0M, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-09-14
- Form: D
- Accession: 0001486189-23-000028
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $200K
- Remaining: $2.8M
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2023-09-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-492121
Issuer
- Name: Vesicor Therapeutics, Inc.
- CIK: 0001993074
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 207 S. SANTA ANITA STREET, SUITE P-15, SAN GABRIEL, CA, 91776
- Phone: (626) 400-6603
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Warren Hosseinionn | Director | Chicago, IL |
| Michael Bowen | Executive Officer | SUWANEE, GA |
| Warren Jr. Hosseinion | Executive Officer | San Gabriel, CA |
| Oded Levy | Director | San Gabriel, CA |
| Luo Feng | Director | San Gabriel, CA |
| Luo Feng | Executive Officer | San Gabriel, CA |
| Warren Hosseinion | Director | Atlanta, GA |
Other filings by this issuer (1)
More